These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 20603835)
1. Isothiocyanate sulforaphane inhibits protooncogenic ornithine decarboxylase activity in colorectal cancer cells via induction of the TGF-β/Smad signaling pathway. Kaminski BM; Loitsch SM; Ochs MJ; Reuter KC; Steinhilber D; Stein J; Ulrich S Mol Nutr Food Res; 2010 Oct; 54(10):1486-96. PubMed ID: 20603835 [TBL] [Abstract][Full Text] [Related]
2. Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling. Oh CJ; Kim JY; Min AK; Park KG; Harris RA; Kim HJ; Lee IK Free Radic Biol Med; 2012 Feb; 52(3):671-682. PubMed ID: 22155056 [TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-β (TGF-β) signaling in healthy human fetal skin: a descriptive study. Walraven M; Beelen RH; Ulrich MM J Dermatol Sci; 2015 May; 78(2):117-24. PubMed ID: 25795202 [TBL] [Abstract][Full Text] [Related]
4. Transforming Growth Factor-β (TGF-β) Inhibits the Expression of Factor VII-activating Protease (FSAP) in Hepatocytes. Leiting S; Seidl S; Martinez-Palacian A; Muhl L; Kanse SM J Biol Chem; 2016 Sep; 291(40):21020-21028. PubMed ID: 27462075 [TBL] [Abstract][Full Text] [Related]
5. Curcumin and emodin down-regulate TGF-β signaling pathway in human cervical cancer cells. Thacker PC; Karunagaran D PLoS One; 2015; 10(3):e0120045. PubMed ID: 25786122 [TBL] [Abstract][Full Text] [Related]
6. Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4. Qiu W; Schönleben F; Li X; Su GH Cancer Lett; 2007 Jan; 245(1-2):163-70. PubMed ID: 16478646 [TBL] [Abstract][Full Text] [Related]
7. A Small Dibromotyrosine Derivative Purified From Pseudoceratina Sp. Suppresses TGF-β Responsiveness by Inhibiting TGF-β Type I Receptor Serine/Threonine Kinase Activity. Chen CL; Kao YC; Yang PH; Sung PJ; Wen ZH; Chen JJ; Huang YB; Chen PY J Cell Biochem; 2016 Dec; 117(12):2800-2814. PubMed ID: 27153151 [TBL] [Abstract][Full Text] [Related]
8. Distinct roles of transforming growth factor-β signaling and transforming growth factor-β receptor inhibitor SB431542 in the regulation of p21 expression. Koo BH; Kim Y; Je Cho Y; Kim DS Eur J Pharmacol; 2015 Oct; 764():413-423. PubMed ID: 26187313 [TBL] [Abstract][Full Text] [Related]
11. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling. Fanayan S; Firth SM; Baxter RC J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851 [TBL] [Abstract][Full Text] [Related]
12. Effects of Chinese traditional compound, JinSanE, on expression of TGF-beta1 and TGF-beta1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo. Song SL; Gong ZJ; Zhang QR; Huang TX World J Gastroenterol; 2005 Apr; 11(15):2269-76. PubMed ID: 15818738 [TBL] [Abstract][Full Text] [Related]
13. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5. Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852 [TBL] [Abstract][Full Text] [Related]
14. Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells. Heldin NE; Bergström D; Hermansson A; Bergenstråhle A; Nakao A; Westermark B; ten Dijke P Mol Cell Endocrinol; 1999 Jul; 153(1-2):79-90. PubMed ID: 10459856 [TBL] [Abstract][Full Text] [Related]
15. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail. Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833 [TBL] [Abstract][Full Text] [Related]
16. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3. Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203 [TBL] [Abstract][Full Text] [Related]
17. Galangin suppresses HepG2 cell proliferation by activating the TGF-β receptor/Smad pathway. Wang Y; Wu J; Lin B; Li X; Zhang H; Ding H; Chen X; Lan L; Luo H Toxicology; 2014 Dec; 326():9-17. PubMed ID: 25268046 [TBL] [Abstract][Full Text] [Related]
18. Restoration of transforming growth factor-beta signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells. Ammanamanchi S; Brattain MG J Biol Chem; 2004 Jul; 279(31):32620-5. PubMed ID: 15155736 [TBL] [Abstract][Full Text] [Related]
19. Solar ultraviolet irradiation reduces collagen in photoaged human skin by blocking transforming growth factor-beta type II receptor/Smad signaling. Quan T; He T; Kang S; Voorhees JJ; Fisher GJ Am J Pathol; 2004 Sep; 165(3):741-51. PubMed ID: 15331399 [TBL] [Abstract][Full Text] [Related]
20. Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines. Kashiwagi Y; Horie K; Kanno C; Inomata M; Imamura T; Kato M; Yamamoto T; Yamashita H Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):679-85. PubMed ID: 19737884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]